tranexamic acid has been researched along with Soft Tissue Neoplasms in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TXA) is poorly studied in patients with bone and musculoskeletal sarcoma due to perceived increased risk of venous thromboembolism (VTE)." | 8.31 | Intravenous tranexamic acid decreases intraoperative transfusion requirements and does not increase incidence of symptomatic venous thromboembolic events in musculoskeletal sarcoma surgery. ( Andrews, NA; Crowley, B; Hess, MC; Howie, C; McGwin, G; Siegel, H; Singh, NP, 2023) |
| "Previous studies have shown that systemic tranexamic acid reduces bleeding during soft tissue surgeries and reduces postoperative ecchymosis and edema experienced by surgical patients." | 8.02 | Effect of Tranexamic Acid Administration on Postoperative Ecchymosis and Edema in Excision of Lipomas. ( Choi, YJ; Kim, WS; Lee, GY; Lee, HJ; Park, HJ, 2021) |
| "Tranexamic acid (TXA) is poorly studied in patients with bone and musculoskeletal sarcoma due to perceived increased risk of venous thromboembolism (VTE)." | 4.31 | Intravenous tranexamic acid decreases intraoperative transfusion requirements and does not increase incidence of symptomatic venous thromboembolic events in musculoskeletal sarcoma surgery. ( Andrews, NA; Crowley, B; Hess, MC; Howie, C; McGwin, G; Siegel, H; Singh, NP, 2023) |
| "Previous studies have shown that systemic tranexamic acid reduces bleeding during soft tissue surgeries and reduces postoperative ecchymosis and edema experienced by surgical patients." | 4.02 | Effect of Tranexamic Acid Administration on Postoperative Ecchymosis and Edema in Excision of Lipomas. ( Choi, YJ; Kim, WS; Lee, GY; Lee, HJ; Park, HJ, 2021) |
| "This study suggests that TXA administration safely and effectively reduces blood loss, in particular for wide resection, with no increase in the rate of adverse events." | 1.72 | Efficacy and safety of tranexamic acid in patients undergoing surgery for bone and soft tissue tumors: a propensity score matching analysis. ( Endo, M; Fujiwara, T; Iida, K; Matsumoto, Y; Nabeshima, A; Nakashima, Y; Oyama, R; Setsu, N, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oyama, R | 1 |
| Setsu, N | 1 |
| Matsumoto, Y | 1 |
| Endo, M | 1 |
| Fujiwara, T | 1 |
| Iida, K | 1 |
| Nabeshima, A | 1 |
| Nakashima, Y | 1 |
| Hess, MC | 1 |
| Andrews, NA | 1 |
| Crowley, B | 1 |
| Singh, NP | 1 |
| Howie, C | 1 |
| McGwin, G | 1 |
| Siegel, H | 1 |
| Choi, YJ | 1 |
| Park, HJ | 1 |
| Lee, HJ | 1 |
| Lee, GY | 1 |
| Kim, WS | 1 |
| Bell, AJ | 1 |
| Chisholm, M | 1 |
| Hickton, M | 1 |
4 other studies available for tranexamic acid and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Efficacy and safety of tranexamic acid in patients undergoing surgery for bone and soft tissue tumors: a propensity score matching analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Humans; Propensity Score; Retrospe | 2022 |
Intravenous tranexamic acid decreases intraoperative transfusion requirements and does not increase incidence of symptomatic venous thromboembolic events in musculoskeletal sarcoma surgery.
Topics: Adult; Humans; Incidence; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tranexamic Acid; Ve | 2023 |
Effect of Tranexamic Acid Administration on Postoperative Ecchymosis and Edema in Excision of Lipomas.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Dermatologic Surgical | 2021 |
Reversal of coagulopathy in Kasabach-Merritt syndrome with tranexamic acid.
Topics: Afibrinogenemia; Blood Coagulation Disorders; Buttocks; Combined Modality Therapy; Cyclohexanecarbox | 1986 |